本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.75
+0.21005.93%
盤前3.810.0600+1.60%05:08 EDT
成交量:1,288.29萬
成交額:4,763.03萬
市值:19.78億
市盈率:-2.60
高:3.75
開:3.57
低:3.56
收:3.54
52周最高:7.18
52周最低:2.80
股本:5.27億
流通股本:4.15億
量比:1.27
換手率:3.10%
股息:- -
股息率:- -
每股收益(TTM):-1.4410
每股收益(LYR):-1.4410
淨資產收益率:-59.54%
總資產收益率:-27.72%
市淨率:1.75
市盈率(LYR):-2.60

資料載入中...

2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities